Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boram Bio is a South Korean biotechnology company that specializes in the development of functional food ingredients and natural-based pharmaceuticals. A subsidiary of the Boram Group, the company was formerly known as SFC Bio and has built a reputation for its research into natural extracts targeting brain health, digestive wellness, and joint support. Their flagship research involves Anticp, a perilla-derived substance aimed at preventing cognitive decline and Alzheimer's disease by inhibiting amyloid-beta accumulation. Boram Bio integrates R&D with manufacturing capabilities to produce a wide range of health functional foods, cosmetics, and raw materials for the global market. The company is actively expanding its portfolio into the silver industry to address the needs of aging populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boram Bio.